Extensive research causally links amyloid-␤ peptide (A␤) to Alzheimer's disease, although the pathologically relevant A␤ conformation remains unclear. A␤ spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A␤. To consistently prepare in vitro oligomeric and fibrillar forms of A␤1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A␤ species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and ϳ40-fold more than unaggregated peptide, with oligomeric A␤1-42-induced neurotoxicity significant at 10 nM. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A␤1-42 from isoforms containing familial mutations Amyloid plaques are one of the pathological hallmarks of Alzheimer's disease (AD).
Amyloid plaques are one of the pathological hallmarks of Alzheimer's disease (AD). 1 Genetic findings over the past decade have further supported the pivotal and likely causal role that amyloid-␤ peptide (A␤) plays in the etiology of AD (1) (2) (3) (4) . This research demonstrates that autosomal dominant mutations affecting the total amount or relative amount of the 42-versus 40-residue form of A␤ are sufficient to cause the disease (for review, see Ref. 5 ). However, a direct causal relationship between amyloid plaques and cognitive impairment remains unclear (6, 7) . This apparent disconnect between plaque burden and neuronal dysfunction and loss has also been described in transgenic mouse models of AD (8, 9) . Recent theories that reconcile these findings point to small soluble oligomeric or protofibrillar assemblies of A␤ that would likely escape the immunostaining and histopathological staining used to detect both diffuse amyloid deposits and senile plaques (10 -13) .
Soluble oligomers of A␤ have been isolated from brain, plasma, cerebrospinal fluid (14, 15) , transfected cells (16) , and cells derived from human brain (11, 17) . In vitro, oligomeric and protofibrillar forms of A␤ have been shown to be directly neurotoxic and inhibit electrophysiologic activity that may be necessary for the formation and maintenance of memory (15, (17) (18) (19) (20) (21) . Experimental in vivo and in vitro evidence linking oligomeric assemblies to neurodegeneration is reflected in a recent revision to the amyloid hypothesis of AD (22) and other diseases involving amyloidogenic proteins (for review, see Ref. 23) . A complete study of A␤, either in vivo or in vitro, requires an understanding of the conditions that drive peptide assembly toward one conformational state or another. Any change that affects the conformation of A␤ likely affects its biological activity.
In light of genetic and in vivo evidence, we have chosen to specifically focus on the longer, more hydrophobic A␤1-42 species. We have determined that the critical initial step in the controlled assembly of A␤1-42 is to remove preexisting structure. Using this chemically and structurally uniform unaggregated starting material, we demonstrate that changes in incubation time, concentration, temperature, ionic strength, and pH result in distinct structural species including soluble oligomers, protofibrils and short fibrils, extended fibrils, and insoluble fibrillar aggregates. We have reported recently (24) that oligomers formed using these methods inhibit neuronal viability 10-fold more than fibrils and ϳ40-fold more than unaggregated peptide, with oligomeric A␤1-42-induced inhibition significant at 10 nM. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A␤1-42 from isoforms containing known familial mutations (24) .
Considering the difficulties in detecting unaggregated and oligomeric A␤ using traditional light and electron microscopy, atomic force microscopy (AFM) was chosen for this study as the primary means of characterizing A␤ assembly state. AFM has proven uniquely well suited to the study of A␤ (15, 18, (25) (26) (27) (28) and other amyloidogenic proteins (29 -31) , because it generates detailed three-dimensional information at a nanometer scale. This technique is capable of characterizing the wide range of structures present in aggregated A␤ mixtures with sufficient resolution to detect individual 0.9-nm structures in unaggre-gated preparations that appear monomeric up to multi-micron dense fibrillar aggregates. For the present study, samples were also characterized by Western blot analysis of SDS-PAGE, a technique used in previous publications to identify SDS-stable A␤ assemblies (11, 16, 17, 19, 24, 32) .
These techniques were used to characterize the structural heterogeneity present in lyophilized stocks of commercial A␤ peptide and define conditions that eliminate any preformed peptide assemblies. Using this common homogeneous unaggregated starting material we characterized how concentration, time, temperature, pH, and ionic strength influence A␤1-42 assembly. In addition, the solubility of these A␤1Ϫ42 preparations was estimated by centrifugation. Finally, solution conditions that favored oligomer and fibril formation for A␤1-42 were applied to A␤1-40.
These results demonstrate the importance of a common homogeneous starting material and how specific conditions determine the formation of distinct conformations of A␤, thus providing the necessary foundation for controlling their assembly. Understanding the biological roles that specific conformations of A␤ play in the pathogenesis of AD may define the link between A␤ and AD, re-focusing therapeutic approaches by identifying the pernicious species of A␤ ultimately responsible for the cognitive dysfunction that is the primary symptom of the disease.
EXPERIMENTAL PROCEDURES
Initial Solubilization of A␤ Peptide-The peptide used in these studies was produced either by chemical synthesis (American Peptide, Sunnyvale, CA) or recombinant expression (Recombinant Peptide Technologies, Athens, GA). Both sources yielded peptide of greater than 95% purity by reverse-phase high performance liquid chromatography and demonstrated the correct molecular mass by mass spectrometry analysis. Lyophilized peptide was stored in sealed glass vials in desiccated containers at Ϫ80°C. Prior to resuspension, each vial was allowed to equilibrate to room temperature for 30 min to avoid condensation upon opening the vial. The first step in resuspending the lyophilized peptide was treatment in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; catalog number H8508; Sigma). All work with HFIP was done in a chemical fume hood with adequate protection. Each vial of peptide was diluted in 100% HFIP to 1 mM using a glass gas-tight Hamilton syringe with a Teflon plunger. The clear solution containing the dissolved peptide was then aliquoted in microcentrifuge tubes (VWR, 20170 -293) using a positive displacement repeat pipette (Multipette; Eppendorf). The HFIP was allowed to evaporate in the fume hood, and the resulting clear peptide films were dried under vacuum (6.7 mtorr) in a SpeedVac (Savant Instruments) and stored desiccated at Ϫ20°C. The HFIPtreated peptide aliquots were re-checked for chemical purity by reversephase high performance liquid chromatography and mass spectrometry. Immediately prior to use, the HFIP-treated aliquots were carefully and completely resuspended to 5 mM in anhydrous dimethyl sulfoxide (D2650; catalog number D-2650; Sigma) by pipette mixing followed by bath sonication for 10 min (model 2120; Branson).
A␤1-42 Oligomer-and Fibril-forming Conditions-A␤1-42 oligomers were prepared by diluting 5 mM A␤1-42 in Me 2 SO to 100 M in ice-cold cell culture medium (phenol red-free Ham's F-12; BioSource), immediately vortexing for 30 s, and incubating at 4°C for 24 h (19). A␤1-42 fibrils were prepared by diluting 5 mM A␤1-42 in Me 2 SO to 100 M in 10 mM HCl, immediately vortexing for 30 s, and incubating at 37°C for 24 h.
CD Spectroscopy-HFIP-treated A␤ (1-40 and 1-42) samples prepared using the methods described above were diluted to 50 M with HFIP. CD spectra were collected on a Jasco J-715 spectropolarimeter. Spectra were obtained from 190 to 260 nm (1-nm steps, 1-nm bandwidth, 20-millidegree sensitivity) in a 0.1-cm path length quartz cell fitted with a Teflon stopper to control for evaporation. All spectra were solvent-subtracted and smoothed with the Savitzky-Golay algorithm according to the manufacturer's instructions provided by Jasco. Spectra were then converted to mean residue ellipticity and fitted by using a linear least squares method with the program CDFIT for Jasco data (JFIT; written by Bernhard Rupp, 1997. This software was provided by Lawrence Livermore National Laboratory, and more information can be found at www-structure.llnl.gov/cd/cdtutorial.htm#Program%20CDFIT).
AFM-Peptide solutions were characterized using a NanoScope IIIa scanning probe work station equipped with a MultiMode head using an E-series piezoceramic scanner (Digital Instruments, Santa Barbara, CA). AFM probes were single-crystal silicon microcantilevers with 300-kHz resonant frequency and 42 Newton/meter spring constant model OMCL-AC160TS-W2 (Olympus). Samples were imaged under dry helium. 10 -50 l of sample solution was spotted on freshly cleaved mica, incubated at room temperature for 5 min, rinsed with 0.02 m of filtered (Whatman Anotop 10) deionized NANOpure water (Barnstad Thermoline), and blown dry with tetrafluoroethane (CleanTex MicroDuster III). Image data were acquired at scan rates between 1 and 2 Hz with drive amplitude and contact force kept to a minimum. Western Blot Analysis of SDS-PAGE-Gel electrophoresis and Western blot analysis were performed according to the manufacturer's protocols (Invitrogen) as described previously (24) . Briefly, unheated samples in lithium dodecyl sulfate sample buffer were applied to 12% bis-Tris NuPAGE gels were electrophoresed using MES running buffer and transferred to 0.45-m polyvinylidene difluoride membrane (Invitrogen). Membranes were blocked in 5% non-fat dry milk in Trisbuffered saline containing 0.0625% Tween 20. Blots were incubated in the primary antibody 6E10 (mouse monoclonal against A␤ residues 1-16; Signet, Dedham, MA) or 4G8 (mouse monoclonal against A␤ residues 17-24; Signet, Dedham, MA). Immunoreactivity was detected using enhanced chemiluminescence (ECL; Amersham Biosciences) and imaged on an Eastman Kodak Co. Image Station 440CF. Molecular weight values were estimated using rainbow pre-stained molecular weight markers (Amersham Biosciences).
Solubility Analysis-A␤1-42 preparations were centrifuged for 30 min at 4°C at either 16,000 ϫ g in an Eppendorf 5415D microcentrifuge (Brinkmann Instruments) or at 100,000 ϫ g in a Beckman Optima MAX ultracentrifuge using a TLA 120.1 rotor in 8 ϫ 34-mm polycarbonate ultracentrifuge tubes (Beckman Coulter Instruments). A␤ supernatant and pellet fractions were extracted by dilution to 70% formic acid (EM Science), bath sonicated (model 2120; Branson) for 5 min, and incubated for 1 h at room temperature. Control samples were prepared in an identical manner using the same tubes and solutions in the absence of centrifugation. Values from these control samples were used to determine non-sedimenting background and were subtracted from test samples. For dot blot analysis, A␤ supernatant and pellet fractions were diluted to 23.3% formic acid in deionized water. Quantitative dot blot analysis was performed using a series 1055 96-well vacuum dot blot apparatus (Invitrogen) fitted with a 0.45-m Immobilon-P membrane (Millipore). 40 l of each diluted fraction was applied to the membrane and developed using the same methods described for Western blot analysis. Quantitation of immunoreactivity was determined using Kodak one-dimensional image analysis software (version 3.5.4).
RESULTS
In vitro studies necessary to define the structure and activity differences between small oligomeric and fibrillar assemblies of A␤ need to be based on procedures that consistently produce fully characterized, homogeneous structural populations. To achieve this goal, the first point to address is the intrinsic structural variability between different lots of A␤ peptide. This variability can exist between chemically identical peptide lots and often results in changes in biological activity in vitro (33, 34) .
HFIP Pretreatment Produces Uniform, Unaggregated Fields of A␤1-42-Removal of any preexisting structures in lyophilized stocks of A␤1Ϫ42 peptide is required for controlled aggregation studies. In this study, lyophilized A␤ directly dissolved to 5 mM in 100% HFIP was characterized by AFM. This treatment resulted in a dense, homogeneous field of unaggregated peptide immediately after resuspension (Fig. 1A) . After a 24-h incubation at room temperature, no aggregates, fibrils, or protofibrils were detected in these HFIP A␤ solutions. The zheight value for the individual peptide structures as measured by AFM was 1.0 (Ϯ 0.3) nm, which agrees the expected size of a single A␤ monomer. However this technique is not capable of absolute molecular weight determination and therefore does not provide proof that these structures are monomeric. HFIP is a corrosive alcohol and is not compatible with in vitro and cell-based assays. For this reason, it was removed by evapora-tion in a fume hood followed by incubation in a 6.7-mtorr vacuum, and samples were stored as peptide films.
Fluorinated alcohols including HFIP and trifluoroethanol have been shown to break down ␤-sheet structure, disrupt hydrophobic forces in aggregated amyloid preparations, and promote ␣-helical secondary structure (35) (36) (37) . CD is commonly used to determine changes in secondary structure averaged for a given sample solution. Thus, CD spectroscopy is a bulk solution technique that might not detect small quantities of fibrillar seeds that differ in secondary structure. A␤ preparations containing primarily fibrillar peptide as determined by electron microscopy produce a CD spectra consistent with a predominately ␤-sheet conformation (38) . However, despite random coil CD spectra, aggregates can be detected by AFM in A␤1-40 directly resuspended in dH 2 O (39). In the present study, using 100% HFIP to remove structural history resulted in CD spectra for A␤1-42 and A␤1-40 solutions indicating a secondary structure almost entirely ␣-helical (ϳ50 -70%) and random coil (ϳ30 -50%), with little ␤-sheet (Ͻ1%) ( Table I ). These data are in agreement with previous CD results using either HFIP or trifluoroethanol to induce ␣-helical structure (36, 40) . Taken together, these CD studies indicate that dissolving A␤1-42 in 100% HFIP removes any preexisting ␤-sheet secondary structure, yielding predominately ␣-helix and random coil. These results are also in agreement with the AFM analysis of A␤1-42 solutions in HFIP that demonstrate the peptide assumes a uniform, unaggregated conformation that shows no signs of aggregation after incubation for 24 h (Fig. 1A) .
Detection of A␤1-42 Fibrils after Direct Resuspension in
Me 2 SO-Me 2 SO is a highly polar, water-soluble organic solvent commonly used to solubilize hydrophobic peptides, including A␤ (41) , and is recommended by commercial suppliers (Bachem). Analytical ultracentrifugation studies have demonstrated that A␤1-40 and A␤1-42 are primarily monomeric in 100% anhydrous Me 2 SO (42, 43) . In the current study, AFM analysis of different commercial lots of synthetic and recombinant A␤1-42 directly resuspended to 5 mM in 100% anhydrous Me 2 SO without HFIP pretreatment demonstrated that the peptide appears primarily unaggregated immediately after solubilization, with structures measuring 1.1 (Ϯ 0.3) nm (Fig. 1A) . However, in some cases small diameter (ϳ2-nm) fibrils were observed (Fig. 1A, inset) . After 24 h at room temperature, additional small A␤ fibrils were detected in A␤1-42 Me 2 SO solutions, even in preparations that were initially fibril-free. These small fibrillar structures were stable in Me 2 SO for several weeks and formed even after HFIP pretreatment (data not shown). These results indicate that 100% anhydrous Me 2 SO alone is not a sufficiently strong solvent to remove all structural history present in lyophilized A␤ or maintain a concentrated unaggregated peptide solution.
Detection of A␤1-42 Fibrils, Protofibrils, Large Aggregates, and Oligomers after Direct Resuspension in Water-Resuspension of lyophilized A␤1Ϫ42 directly in dH 2 O or aqueous buffer is also used by investigators (44, 45) and recommended by commercial manufacturers (AnaSpec, Bachem, U.S. Peptide, Inc.). To determine the extent of structural heterogeneity present in lyophilized stocks of A␤1-42, peptide was directly resuspended to 5 mM in dH 2 O and characterized by AFM. Analysis of these solutions revealed a wide size range of peptide aggregates and extended fibrils immediately after resuspension (Fig. 1A) . These structures included large (10 -15-nm z-height) and small (2-5-nm z-height) amorphous peptide aggregates and intermediate diameter fibrils (4 -6 nm) greater than 1 m in length. These structures persisted after 24 h at room temperature, in addition to an increase in the number of 2-5-nm globular aggregates. However, the extent of all the structures observed under these conditions is highly dependent on seeded aggregation and thus dependent on the initial lyophilized peptide. These data indicate that direct resuspension of lyophilized A␤1-42 in dH 2 O produces heterogeneous structural populations incompatible with controlled aggregation studies. Note that the z-height range for this H 2 O preparation was maintained at 5 nm, resulting in a greater contrast compared with images of HFIP-and Me 2 SO-solubilized peptide.
Solubilization of HFIP-treated Peptide in Me 2 SO Produces a Uniform, Unaggregated
Field of A␤1Ϫ42-To ensure that the HFIP-treated A␤1-42 peptide film was fully solubilized, peptide stocks were resuspended to 5 mM in Me 2 SO. The resulting solution contained unaggregated structures (Fig. 1B) that measured 1.0 (Ϯ 0.3) nm by AFM (Fig. 1B, inset) , comparable with the measurements for A␤1-42 structures measured directly in HFIP or Me 2 SO (Fig. 1A) . Solubilization of the HFIPtreated peptide directly into dH 2 O or aggregation buffer does not produce a fully resuspended unaggregated solution. The thin film resulting from the HFIP treatment is not easily resuspended directly in dH 2 O without the use of sonication or other methods. The peptide film is more soluble in Me 2 SO facilitating complete resuspension of the HFIP-treated peptide (data not shown).
Solution Conditions for the Formation of Oligomeric or Fibrillar A␤1-42
Assemblies-Once conditions were established that consistently produce unaggregated A␤ preparations, two different aggregation protocols were used with the HFIP-treated Me 2 SO peptide stocks. Previous studies demonstrated the formation of small soluble oligomeric assemblies derived from A␤1-42 either incubated in the presence of apolipoprotein J under physiologic conditions (18) or in cell culture medium where the oligomeric assemblies were referred to as ADDLs (amyloid-derived diffusible ligands) (19) . For the studies presented herein, the cell culture medium method with a 24-h incubation at 4°C was used for oligomer formation. For the fibril-forming conditions, previous studies have indicated that acidic pH favors fibrillogenesis for A␤ (46, 47) and other amyloid-forming proteins (48 -50) . The acidic pH method using 10 mM HCl with a 24-h incubation at 37°C was chosen for fibril formation. The resulting oligomeric and fibrillar A␤1Ϫ42 structures were characterized by AFM ( Fig. 2A) and Western blot analysis of SDS-PAGE (Fig. 2B) .
Immediately after resuspension under both the oligomerand fibril-forming conditions, the majority of A␤1-42 remained as unassembled structures measuring ϳ1.0 nm ( Fig. 2A, insets) , although a few oligomers measuring between 2 and 4 nm were also detected ( Fig. 2A) . After a 24-h incubation under oligomer-forming conditions, A␤1-42 assembled into predominantly 2-4-nm oligomeric structures ( Fig. 2A) . No fibril formation was detected under these conditions. Within 24 h under fibril-forming conditions, A␤1-42 converted to ϳ4-nm amyloid fibrils that extended over several microns, some of which had a semi-periodic structure along the fibril axis. As previously reported, AFM measurements may underestimate the diameter of A␤ structures because of sample compression by the AFM probe (25, 51) .
Western blot analysis of SDS-PAGE revealed A␤1-42 monomer, trimer, and tetramer for unaggregated (0 h) samples incubated under both oligomer-and fibril-forming conditions (Fig. 2B, lanes 1 and 3, respectively) . Larger oligomeric assemblies ranging from 30 to 60 kDa were detected after incubation for 24 h under oligomer-forming conditions. Additionally, there was an increase in the trimer and tetramer bands, as well as smearing between tetramer and monomer, possibly indicating interconversion between these assemblies during electrophoresis (Fig. 2B, lane 2) . After 24 h, A␤1-42 samples incubated under fibril-forming conditions contained high molecular weight immunoreactive A␤ that remained in the well, less abundant 30 -60-kDa large oligomers, and a smear between tetramer and monomer (Fig. 2B, lane 4) . The abundant tetramer detected after 24 h under oligomer-forming conditions was not present under fibril-forming conditions, although the increase in the trimer band and smearing between trimer and monomer were present in both preparations at 24 h.
Western analysis of SDS-PAGE for A␤1-42 oligomers and fibrils was variable. In our previous report we observed more SDS-stable structures between monomer and tetramer, particularly dimer, in the 24-h fibril preparations than reported herein (24) . Common trends observed in both studies for oligomeric preparations include detection of an abundant tetramer and trimer. Fibril preparations typically include less abundant tetramer and the presence of Ͼ60-kDa large aggregates, including A␤ immunoreactive material that remains in the well of the gel. Unaggregated (0 h) A␤1-42 samples typically contain some trimer and tetramer, in addition to monomer. Comparable results are obtained with A␤ monoclonal antibodies 6E10, recognizing A␤ residues 1-16 (Fig. 2B) , and 4G8, recognizing A␤ residues 17-24 (data not shown). The NuPAGE gel system used in these studies yields slightly different banding patterns with these two antibodies than Tris/Tricine and Tris/ glycine gels where more dimer is detected (data not shown). Thus, in contrast to the limited and variable information gained by the gel-dependent detection of SDS-stable A␤ structures, AFM analysis clearly differentiates between oligomeric and fibrillar A␤1-42 structures that form under the conditions described for these experiments.
A␤1-42 Assembly Is Dependent on Incubation Time and Peptide Concentration-Total
peptide concentration is known to influence the fibrillogenesis of A␤ (47) . To determine how A␤ peptide concentration affects assembly under oligomer-and fibril-forming conditions, A␤1-42 concentrations ranging from 10 to 100 M were prepared and analyzed immediately after dilution (0 h), after 24 h, and after 1 week.
Immediately after dilution, 2-4-nm A␤1-42 oligomers formed rapidly under the oligomer-forming conditions at concentrations greater than 25 M (Fig. 3A, 0 h) . In general, a concentration-dependent increase in the number of 2-4-nm oligomers was observed between 10 and 100 M for all three incubation periods (Fig. 3A) . After 24 h, a slight increase in the number of 2-4-nm oligomers, but no fibril formation, was detected at each of the four concentrations (Fig. 3A, 24 h) . After 1 week, a concentration-dependent increase in protofibrils (measuring Ͻ200 nm) and some short fibrils both straight and curved (measuring Ͻ1 m) were observed in the oligomer preparations at 50 and 100 M, with very few protofibrils in 25 M samples, and no protofibrils in the 10 M A␤1-42 solutions (Fig. 3A, 1 week) . Of interest, no mature fibrils (measuring Ͼ1 m) were detected at any of the time points or concentrations despite the detection of protofibrils and short fibrils, particularly abundant at 100 M and 1-week incubation time. These results demonstrate that A␤1-42 rapidly forms oligomers under these conditions and that only after extended incubation at A␤1Ϫ42 concentrations Ն 25 M were significant numbers of protofibrils and slightly longer structures detected.
Under fibril-forming conditions, immediately after dilution A␤1-42 forms 2-4-nm oligomers, in addition to some protofibrils at 50 and 100 M (Fig. 3B, 0 h ). After incubation for 24 h, no fibril formation could be detected at 10 M, and mixed individual 4-nm fibrils, protofibrils, and oligomers were detected at 25 M, 4-nm fibrils mixed with some 2-4-nm oli- 4. A␤1-42 assembly is dependent on temperature. A, AFM. A␤1-42 oligomers and fibrils prepared as described in the legend for Fig.  2 were incubated at 4°C, room temperature, or 37°C for 24 h. Representative 2 ϫ 2-m x-y, 10-nm total z-range AFM images are shown. B, Western analysis of SDS-PAGE. Representative Western blots of samples prepared as described for A and analyzed as described in the legend for Fig. 2 are shown. The figure shows oligomers and fibrils at 4°C (lanes 1 and 4), room temperature (lanes 2 and 5), and 37°C (lanes 3 and 6) , respectively.
gomers were present at 50 M, and dense networks of ϳ4-nm fibrils were present at 100 M. After 1 week, only oligomeric and protofibrillar structures could be detected at 10 M A␤1-42. At 25 M, mixed oligomeric, protofibrillar, and fibrillar A␤1-42 structures were observed, with the fibrils appearing more rigid than at 24 h. At both 50 and 100 M, dense fields fibrils were present. These results indicate that A␤1-42 incubated under fibril-forming conditions results in concentrationand time-dependent fibril formation and that under these conditions, homogeneous fibril populations form within 24 h at 100 M A␤1-42 and are stable for at least 1 week.
A␤1-42 Assembly Is Dependent on Temperature-Temperature has been shown previously to be an important factor in fibril assembly (52) . Here we investigated the effects of temperature on oligomer-and fibril-forming conditions. Solutions of 100 M A␤1-42 incubated at 4°C under the standard oligomer-forming conditions were also incubated at room temperature and 37°C. Solutions of 100 M A␤1-42 incubated at 37°C under the standard fibril-forming conditions were also incubated at room temperature and 4°C. The resulting structures were characterized by AFM (Fig. 4A) and Western blot analysis of SDS-PAGE (Fig. 4B) .
Under oligomer-forming conditions (4°C), 100 M A␤1-42 incubated for 24 h produced homogeneous solutions of 2-4-nm oligomers comparable with Fig. 2A (Fig. 4A, 4°C) . At room temperature, the solution remained predominately oligomeric with a low concentration of short protofibrils (Fig. 4A, RT) . At 37°C, the solution contained both oligomers and an increased number of protofibrils (Fig. 4A, 37°C) . These results indicate that uniform populations of oligomers form at 4°C, and increasing temperature produces limited protofibril formation within 24 h at 100 M A␤1-42. However, as with incubation time and peptide concentration, although protofibrils were present, no extended fibrils were observed with the oligomerforming conditions at any of the temperatures.
Under fibril-forming conditions (37°C), 100 M A␤1-42 incubated for 24 h produced extended ϳ4-nm fibrils, comparable with Fig. 2A (Fig. 4A, 37°C) . When the incubation temperature was lowered to room temperature, A␤1-42 continued to form extended fibrils, although an increase in the oligomeric background was observed (Fig. 4A, RT) . Solutions incubated at 4°C contained predominately unassembled peptide and 2-4-nm oligomeric structures, in addition to a sparse population of 2-4-nm-diameter fibrils less than 2 m in length. In summary, incubation at 37°C produces the most uniform fibril populations, with fibril density decreasing significantly with temperature.
Western blot analysis of SDS-PAGE of A␤1-42 incubated under oligomer-forming conditions detected SDS-stable tetramer, trimer, and monomer (Fig. 4B, lane 1) . When the incubation temperature was raised to room temperature and 37°C, there was a decrease in the amount of monomer and an increase in the presence of large oligomers (Fig. 4B, lanes 2 and  3) . Under fibril-forming conditions, the majority of the large fibril assemblies were not SDS-stable as A␤ appeared as monomer, trimer, and tetramer, and decreasing temperature induced an increase in the amount of trimer and tetramer (Fig.  4B, lanes 4 -6) .
A␤1-42 Assembly Is Dependent on Ionic Strength and pHTwo primary differences between the oligomer-and fibril-forming conditions are ionic strength and pH. For the oligomerforming conditions, A␤1-42 is incubated in cell culture medium at physiologic ionic strength and neutral pH. For fibril-forming conditions, A␤1-42 is incubated in dilute HCl at low ionic strength and acidic pH. To determine how the combination of ionic strength and pH influence the assembly of A␤1-42, 100 M A␤1-42 solutions were incubated at 37°C at acidic pH and neutral pH and at both low and physiologic ionic strength. At acidic pH and low ionic strength (standard fibrilforming conditions), extended ϳ40-nm fibrils were detected by AFM, comparable with Fig. 2A (Fig. 5A) . Adding 150 mM NaCl while maintaining the acidic pH resulted in the formation of dense fibrillar aggregates that vary in z-height from 5 to greater than 25 nm (Fig. 5A) . Note that the z-height range FIG. 5 . A␤1-42 assembly is dependent on ionic strength and pH. A, AFM. 5 mM A␤1-42 in Me 2 SO stocks were diluted to 100 M in either 10 mM HCl (low ionic strength, acidic pH), 10 mM HCl ϩ 150 mM NaCl (acidic pH, physiologic ionic strength), 10 mM Tris, pH 7.4 (neutral pH), or 10 mM Tris, pH 7.4, ϩ 150 mM NaCl (neutral pH, physiologic ionic strength). Samples were prepared after a 24-h incubation at 37°C. Representative 2 ϫ 2-m x-y, 10-nm total z-range AFM images are shown, except for the image of the acidic pH, physiologic ionic strength condition, which is scaled to 2 ϫ 2-m x-y, 25-nm total z-range. B, Western analysis of SDS-PAGE. Representative Western blots of samples prepared as described for A and analyzed as described in the legend for representation for this image was increased from 10 to 25 nm because of the size of the fibrillar aggregates. At neutral pH and low ionic strength, A␤1-42 solutions remained primarily oligomeric comparable with Fig. 2A , in addition to several short fibrils (Fig. 5A ). When the pH was neutral, and 150 mM NaCl was added, A␤1-42 oligomers coalesced into primarily small oligomeric aggregates with z-height values measuring ϳ5-8 nm and protofibrils.
Oligomer formation was favored at neutral pH and physiologic ionic strength. However, some differences were present between A␤1-42 assemblies formed in F-12 culture medium ( Fig. 2A) and in a buffered salt solution (Fig. 5A) . In F-12 culture medium, more evenly dispersed fields of 2-4-nm oligomers were observed by AFM, whereas A␤1-42 incubated in buffered salt solutions yielded more aggregated clusters of oligomers and protofibrils. This may result from the differences in the inorganic salts or the presence of trace metals and/or amino acids in F-12 culture medium, initially selected based on oligomer-forming conditions reported in the literature (19) . In an effort to simplify the oligomer-forming solution, several solutions of comparable pH and ionic strength were screened, including Dulbecco's modified Eagle's medium, artificial cerebral spinal fluid, and buffered salt solutions containing trace metals and N,N-dimethylglycine in place of individual amino acids. Although A␤1-42 formed oligomeric assemblies in each of these solutions as determined by AFM (data not shown), globular structures were present in solution controls in the absence of A␤, confounding the detection of A␤ oligomers prepared in these solutions. Ultimately, the most consistent preparations with the lowest background levels for AFM were obtained using F-12 cell culture medium.
Western blot analysis of SDS-PAGE revealed that samples prepared at acidic pH and low ionic strength contained A␤1-42 tetramer, trimer, and monomer (Fig. 5B, lane 1) . The addition of 150 mM NaCl at acidic pH corresponded to a slight decrease in trimer and a slight increase in large oligomers (Fig. 5B, lane  2) . When A␤1-42 was incubated at neutral pH and low ionic strength, a prominent smear of large oligomers was detected, in addition to A␤ tetramer, trimer, and monomer. The addition of 150 mM NaCl at neutral pH resulted in a decrease in the large oligomers (Fig. 5B, lane 4) relative to the same sample incubated without additional NaCl. The relative similarity between acidic pH samples analyzed by Western blot indicates that most of the dramatic conformational differences detected by AFM cannot be detected by Western analysis of SDS-PAGE.
Solubility of A␤1-42 Assemblies-Sedimentation analysis has been used previously (53, 54) to characterize the aggregation state of A␤ under a variety of conditions. In the present study, the solubilities of unaggregated A␤1Ϫ42, oligomers, and fibrils ( Fig. 2 ) and the fibrillar aggregates (Fig. 5A , acidic pH and physiologic ionic strength) were estimated after centrifugation for 30 min at 16,000 and 100,000 ϫ g. The soluble A␤1-42 structures remaining in the supernatants were characterized by AFM. Unaggregated A␤1-42 total and supernatant fractions (Fig. 6 ) contained structures that measured 1.0 (Ϯ 0.3) nm (Fig. 6, insets) and very few oligomeric assemblies. The total oligomeric and fibrillar A␤1-42, as well as the 16,000 and 100,000 ϫ g supernatants (Fig. 6) , were comparable in size and morphology to the assemblies described for Fig. 2A . A decrease in the number of fibrils was observed in the 100,000 ϫ g supernatant fraction, indicating that these fibrils may eventually sediment with prolonged ultracentrifugation. In contrast, fibrillar aggregates could not be detected by AFM in either 16,000 or 100,000 ϫ g supernatants. No unassembled or oligomeric structures were detected in the fibrillar aggregate 100,000 ϫ g supernatant fraction at high resolution by AFM (Fig. 6, inset) .
Approximately 90% of the total A␤ peptide remained in the supernatants when unaggregated, oligomeric, and fibrillar preparations were centrifuged at 16,000 ϫ g for 30 min (Table  II) . Fibrillar aggregates were more insoluble yielding ϳ23% recovery from the 16,000 ϫ g supernatants. Unaggregated and oligomeric preparations remained in the supernatant at 100,000 ϫ g, whereas the fibrillar conformations began to sediment with ϳ51% remaining in the supernatant. Fibrillar aggregates completely sedimented at 100,000 ϫ g. These percentrecovery results (Table II) agree with the presence of unaggregated, oligomeric, and fibrillar assemblies detected by AFM in supernatant fractions (Fig. 6 ). In addition, the absence of fibrillar aggregates in 16,000 and 100,000 ϫ g supernatants (Fig. 6 ) coincides with low percent-recovery data (Table II) . Taken together, these data indicate that unaggregated, oligomeric, and to some extent fibrillar, preparations of A␤1-42 are soluble and that fibrillar aggregates formed at physiologic ionic strength and acidic pH are insoluble.
A␤1-40 Requires Longer Incubation Times to Form Oligomers and Fibrils Comparable with A␤1-42 Oligomers and
Fibrils-A␤1-40 is the predominant species of A␤ produced from the variable C-terminal cleavage of APP. The oligomerand fibril-forming conditions defined for A␤1-42 were applied to A␤1-40. AFM characterization of A␤1-40 immediately upon dilution reveals a fairly homogeneous field of unaggregated peptide structures (Fig. 7A) . High resolution scans detect dense fields peptide measuring 1.0 (Ϯ0.3) nm (Fig. 7A, insets for 0 h) . No significant changes in A␤1-40 assembly state could be detected under the A␤1-42 oligomer-or fibril-forming conditions by AFM after 24 h (Fig. 7A) , although some short, ϳ4-nm-diameter A␤1-40 fibrils and 2-4-nm oligomers were detected under fibril-forming conditions. Both A␤1-40 solutions were allowed to incubate for 6 weeks. At this time point, ϳ4-nm assemblies comparable in size to 24-h A␤1-42 oligomers in Fig.  2A were detected under oligomer-forming conditions (Fig. 7A) . At 6-weeks, solutions of A␤1-40 incubated under fibril-forming conditions contained several 2-6-nm oligomeric assemblies and ϳ4 -6-nm-diameter fibrils (Fig. 7A) , slightly larger than 24-h A␤1-42 fibrils (ϳ4 nm) in Fig. 2A .
Western blot analysis of SDS-PAGE for A␤1-40 incubated under oligomer (Fig. 7B, lanes 1 and 2)-and fibril (Fig. 7B,  lanes 3 and 4) -forming conditions revealed A␤ tetramer and monomer in both preparations at 0 (Fig. 7B, lanes 1 and 3) -and 24 (Fig. 7B, lanes 2 and 4) -h time points. Faint bands of larger oligomers between 30 and 60 kDa are present in both 24-h samples, and a faint smear centered at ϳ60 kDa can be detected in the 24-h sample incubated under fibril-forming conditions. Western blot analysis of long-aged A␤1-40 under oligomer-forming conditions (Fig. 7B, lane 5 ) reveals monomer and a smear around ϳ60 kDa. Long-aged A␤1-40 solutions incubated under fibril-forming conditions (Fig. 7B, lane 6 ) contain a faint monomer band, a smear around ϳ60 kDa, and large aggregates Ͼ60 kDa extending up to the well of the gel. DISCUSSION The biological roles that A␤ plays in normal humans or in those that suffer from AD remain unclear. Definitive genetic studies, as well as a large number of in vitro and in vivo experiments, provide compelling evidence that A␤1-42 is a direct causal agent for AD. What remains unclear is the relevant conformational assembly(s) of A␤1Ϫ42 associated with the disease pathology. Early studies provided evidence that A␤ had to assemble into a fibrillar conformation to induce significant levels of neurotoxicity in vitro (55) (56) (57) or A␤-induced tau phosphorylation (58) . Recently, a number of studies have uncovered both in vitro and in vivo biological activities associated with soluble oligomeric and protofibrillar conformations of A␤, challenging the idea that fibrillar amyloid is the causative pathogenic agent in AD. The first studies that characterized soluble oligomeric A␤ (18), a dimer-containing A␤1-42 fraction (15), ADDLs (amyloid-derived diffusible ligands) (19) , and protofibrils (51, 59) introduced the concept that amyloid fibrils are not the only biologically relevant A␤ conformation.
In the present study, A␤1-42 pretreated in HFIP and solubilized in Me 2 SO produced uniform peptide solutions that were free from the structural history present in commercially available lyophilized stocks, laying the critical foundation for controlled aggregation studies. From this structurally and chemically identical starting material, conformationally distinct populations of oligomeric and fibrillar A␤ were produced by controlling the incubation time, concentration, temperature, pH, ionic strength, and A␤ species. Incubation time had a moderate effect on A␤1Ϫ42 conformation in that the majority of the structures that formed within 24 h remained for up to 1 week. Concentration also had a moderate effect on conformation, particularly fibril formation, as the critical concentration for fibrillogenesis under these conditions appears to be between 10 and 50 M, whereas oligomer formation can proceed at much lower concentrations (Fig. 3) . Temperature also appeared to influence the rate of fibril formation to a greater extent than oligomer formation. Oligomer and protofibril formation was favored at neutral pH, and fibril formation was favored at acidic pH. Ionic strength had a significant effect on conformation, particularly the coalescence of soluble fibrillar A␤1-42 into compact insoluble fibril aggregates at 150 mM NaCl. When these oligomer-and fibril-forming conditions for A␤1-42 were applied to A␤1-40, significantly longer periods of time were required for oligomeric and fibrillar structures to form that resembled those formed by A␤1-42 within 24 h. Taken together, these results define specific conditions for reproducibly controlling the formation of unaggregated, oligomeric, fibrillar, and fibrillar aggregate conformations of A␤1-42.
In vitro biological activity studies have demonstrated that oligomeric (17) (18) (19) 21) and protofibrillar (20, 60) conformations of A␤ are neurotoxic and impair electrophysiologic activity. Although experiments using a single conformation of A␤ can be informative, comparative experiments using multiple conformations of A␤ derived from a single starting material will further our understanding of how structure affects function. Using this approach, we demonstrated recently (24) a significant difference in neurotoxicity among unaggregated, oligomeric, and fibrillar A␤1-42. Oligomers inhibited neuronal viability 10-fold more than fibrils and ϳ40-fold more than unaggregated peptide, with oligomer-induced toxicity significant at 10 nM. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A␤1-42 from isoforms containing known familial mutations (24) . An in vitro comparative analysis using these preparations also demonstrated a significant increase in glial activation by A␤1-42 oligomers compared with fibrils, as measured by morphological changes and increased expression of inflammatory markers including nitric oxide, inducible nitric-oxide synthase, and interlukin-1␤. 2 The variability in A␤ activity reported in the literature is likely because of the structural heterogeneity present in com-2 M. J. LaDu and L. J. Van Eldik, unpublished observations.
TABLE II
Quantitation of the solubility of A␤1-42 assemblies 100 M unaggregated, oligomeric, fibrillar, and fibrillar aggregates of A␤1-42 were prepared as described in the legend for Fig. 6A . Samples diluted 1:10 were either not centrifuged (total) or centrifuged for 30 minutes at 16,000 ϫ g or 100,000 ϫ g. Total, supernatant, and pellet fractions were extracted in 70% formic acid and quantitated by dot blot analysis. Values represent means (Ϯ S.E.M) of the percent recovery of the total (uncentrifuged) in the supernatant and pellet fractions. Control samples were prepared in an identical manner using the same tubes and solutions in the absence of centrifugation. Values from these control samples were used to determine non-sedimenting background and were subtracted from test samples. mercial preparations that are chemically identical. Commercial sources of synthetic A␤ suggest resuspension in either H 2 O or Me 2 SO, and these solubilization procedures are reported throughout the literature. In this study, AFM analysis of lyophilized A␤ stocks directly resuspended in H 2 O detected a wide variety of structures including oligomers, fibrils, and globular aggregates. These structures could seed further aggregation, strongly influencing the formation and biological activity of the resulting solutions. Seed-free preparations of A␤ have been described using the polar solvent Me 2 SO, in conjunction with bath sonication and/or filtration (61, 62) . Surprisingly, in this study AFM analysis of A␤ solutions in Me 2 SO that appeared initially uniform and unaggregated revealed fibril formation over time. Previous studies characterizing the formation of A␤ protofibrils (59) and oligomers (63) have emphasized the importance of removing preexisting seeds from A␤ stocks by size-exclusion chromatography. Although this approach appears to be successful, it is not always practical for the routine preparation of the large number of small peptide aliquots frequently required for biological assays or screening. Centrifugation is another method commonly used to separate soluble A␤ from insoluble fibrillar amyloid in both extracted tissue (64, 65) and in vitro aggregation preparations (66, 67) . In this study, the fibrillar aggregates formed at acidic pH and physiologic ionic strength were insoluble and sedimented upon centrifugation at both 16,000 and 100,000 ϫ g (see Fig. 6 and Table II) . However, fibrillar preparations of A␤1-42 remained in the supernatant at 16,000 ϫ g and only partially sedimented at 100,000 ϫ g (see Fig. 6 and Table II) . Although these results confirm the solubility of unaggregated and oligomeric A␤1-42 preparations, and the insolubility of fibrillar aggregates, the importance of differentiating between preparations defined as "soluble" versus those that are truly "fibril-free" is emphasized by the solubility of fibril preparations. The A␤ structural conformations that formed under the conditions used in this study were readily discriminated by AFM, whereas Western blot analysis of SDS-PAGE provided only limited information. In light of the structural differences detected by AFM, it is clear that some of the A␤1-42 and A␤1-40 assemblies that form under the oligomer-and fibril-forming conditions used in this study dissociate during SDS-PAGE. In particular, the distinct structural morphologies in A␤1-42 resulting from changes in pH and ionic strength detected by AFM (Fig. 5A) could not be differentiated clearly by Western blot analysis of SDS-PAGE (Fig. 5B) . In addition, the electrophoretic process and the combination buffer, glycerol, and detergent present in SDS sample buffer may actually induce the formation of SDS-stable oligomers as reported previously (68) . This may account for the SDS-stable oligomers, trimers, and tetramers detected in preparations of A␤1-40 and A␤1-42 that appeared unaggregated by AFM (see Figs. 2, 6, and 7) . In addition, when distinct A␤1-40 oligomers and fibrils were detected by AFM, no SDS-stable oligomeric bands were present.
Despite these limitations, some general trends were observed between Western blot analysis of SDS-PAGE of A␤1-42 preparations incubated under oligomer-and fibril-forming conditions. Oligomers produced slightly more SDS-stable tetramer and large oligomer bands than fibrils, and both conditions showed more SDS-stable trimer and tetramer than unaggregated peptide. Under fibril-forming conditions, the amount of SDS-stable trimer and tetramer appears to vary and may be in equilibrium with unstable assemblies that break down to monomer, the primary conformation observed in fibril preparations in our previous study (24) . An indication of this molecular rearrangement between monomer and tetramer was indicated by the pronounced boundary and smear between these bands (Fig. 2B, lanes 2 and 4) . These intermediates appear unstable during SDS-PAGE and form under both oligomer-and fibrilforming conditions. Interestingly, unaggregated preparations (Fig. 2B, lanes 1 and 3) that did contain some trimer and tetramer did not contain a smear between tetramer and monomer.
A more accurate representation of the molecular stoichiometry of the different assemblies as they exist in solution may require covalent cross-linking. This strategy was used recently (69) to demonstrate the complexity and dynamic nature of the prenucleation phases of A␤1Ϫ40 assembly and specifically detected oligomeric intermediates that were not SDS-stable. Further evidence that SDS-PAGE alone cannot detect A␤1Ϫ40 monomer-oligomer distribution as it exists in solution comes from studies using analytical ultracentrifugation (63) and mass spectrometry (70) . These studies, like the covalent cross-linking study, revealed a more complex, dynamic equilibrium be- 1 and 3) , 24 h (lanes 2 and 4), and 6 weeks (lanes 5 and 6), respectively. tween monomer and oligomer. Thus, it does not appear possible to equate an aggregate conformation of A␤1-40 or 1-42 as visualized by AFM to a particular molecular weight band from Western blot analysis of SDS-PAGE.
In general, ionic interactions are influenced by pH. In this study, solution pH significantly effected both oligomer and fibril assembly. Acidic pH has been shown previously (36, 71, 72) to favor fibril formation, possibly resulting from a partial denaturation state similar to that observed with other amyloidforming proteins (73) . This may be the result of protonation of the C-terminal carboxyl, N-terminal Asp 1 , Glu 23 -Asp 24 , His 13 -His 14 , or other Asp, Glu, or His residues. These charged amino acids may be involved in the stabilization of the local secondary structure that facilitates fibrillogenesis. Studies of modified A␤1-40, in which Asp or His residues were replaced by Asn and Gln, demonstrated that a strong relationship exists between the protonation state at these positions and ␣-helical content (74) . Fibrillogenesis is thought to proceed through an ␣-helical intermediate, and stabilization of local helical structure can accelerate this process (40) . This may account for the very rapid conversion of unassembled A␤1-42 to extended fibrils within 24 h of incubation at acidic pH as observed in this study.
In addition to ionic interactions influenced by solution pH, hydrophobic interactions also appear to have a significant effect, particularly on fibril formation. At low ionic strength, A␤1-42 fibrils form but remain as individual extended structures for at least a week (Fig. 3B) and are resistant to sedimentation (see Fig. 6 and Table II) . However, the salt-dependent coalescence of A␤1Ϫ42 fibrils into supramolecular fibril aggregates (see Fig. 5A and Fig. 6 ) argues that exposed hydrophobic patches present on the surface of A␤1-42 fibrils can drive the formation of dense, insoluble fibrillar aggregates. Alternatively, this process may be the result of polar interactions screened by the increased ionic strength, although it is more likely that the fibrillar aggregates resulted from nonpolar surface interactions. Interestingly, the presence or absence of 150 mM NaCl did not have as significant of an effect on the coalescence of primarily oligomeric assemblies formed at neutral pH (Fig. 5A) , indicating that these oligomeric assemblies may have already sequestered non-polar surfaces by adopting a favorable conformation.
Further evidence supporting the role of hydrophobic interactions comes from the dramatic differences between A␤1-42 and A␤1-40 conformations that were observed by AFM under the A␤1-42 fibril-and oligomer-forming conditions. The additional hydrophobic Ile-Ala residues found at the C termini of A␤1-42 were necessary for the fibril and oligomer formation within 24 h as detected by AFM, as well as the different patterns of SDS-stable assemblies detected by Western blot analysis of SDS-PAGE. Therefore, these hydrophobic residues in A␤1-42 appear to play an important role in vitro in the formation of stable oligomers fibrils. These findings provide evidence that hydrophobic forces play an important role in both differentiating A␤1-40 and A␤1-42 species and in the formation of oligomeric and fibrillar aggregates of A␤1-42.
Polarity changes induced by protein oxidation may influence both ionic and hydrophobic interactions. In particular, oxidation of A␤ at methionine 35 alters the polarity at that position and may influence hydrophobic or ionic interactions necessary for fibril formation (28) . In this recent study, AFM analysis differentiated A␤1-42 solutions containing mixed short fibrils from A␤1-42Met35 ox solutions containing only small, nonfibrillar aggregates. These results further emphasize how the distribution of oligomeric and fibrillar A␤1-42 assemblies is affected by factors that influence molecular interactions.
The physical presence of amyloid plaques in vivo demonstrates that at some point, favorable conditions exist for their formation. However, in vitro fibril formation occurs in solution conditions and at A␤ concentrations that are decidedly nonphysiologic. The trends observed in this study suggest that at lower concentrations and under physiologic solution conditions A␤1-42 adopts a favorable, stable oligomeric conformation. At higher peptide concentrations and elevated temperature under oligomer-forming conditions, soluble oligomeric, protofibrillar, and short fibrillar conformations coexist, indicating that these structures may be in a conformational equilibrium. However, it is unlikely that these soluble assemblies represent on-pathway fibril intermediates under the oligomer-forming conditions used in this study. If this were the case, then increasing the peptide concentration, increasing temperature, or extending the incubation time would result in the rapid conversion of oligomeric, protofibrillar, and short fibrillar conformations to mature fibrillar conformations Ͼ1 m in length. This result was not observed (see Fig. 3A and Fig. 4A) . In vitro studies characterizing A␤ protofibrils as metastable fibril precursors demonstrated that in the absence of fibrillar seeds, the conversion of protofibrils to mature amyloid fibrils is a slow process (26) . Additionally, the authors noted a disappearance of protofibrils that preceded the appearance of mature fibrils (26, 51) , and in vitro dialysis experiments using radiolabeled A␤ indicate that protofibrils are in equilibrium with low molecular weight A␤ (60) . Whether in vivo oligomeric and protofibrillar forms of A␤1-42 represent stable end point assemblies that dissociate to monomer before proceeding to form mature fibrils via a nucleation-dependent polymerization mechanism remains to be determined. Amyloid deposits that form in vivo may result from microenvironments where nucleation-dependent polymerization can proceed and are only indirectly responsible for neurodegeneration and cognitive impairment in AD. However, a second and potentially more biologically significant soluble pool of oligomeric and/or protofibrillar A␤ favored by A␤1-42 may play a more direct and deleterious role in AD pathology. These remaining mechanistic questions can be addressed by additional kinetic studies.
Evidence in the literature continues to build supporting a central causative role for A␤ in the neuropathology of AD. With increased significance comes an increased need for a better understanding of how A␤ structure affects function. The in vitro experiments reported in this study provide unique insights into the conditions that control the complex process of A␤ assembly by utilizing a single, homogenous starting material to produce multiple, distinct conformational species by varying the incubation conditions. Understanding the assembly and biological activity of both oligomeric and fibrillar forms of A␤ is important both mechanistically and because it influences whether therapeutic strategies in AD are best aimed at eliminating oligomeric assemblies of A␤ or plaque deposition. Furthermore, therapeutic approaches solely focused on fibril destabilization may have the undesirable side effect of increasing a soluble pool of neurotoxic A␤ oligomers and protofibrils. Experiments that take into account A␤ conformational differences will yield more consistent and interpretable results, providing the biological infrastructure for developing successful therapeutics for the treatment of AD.
